Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.
<h4>Background</h4>Pneumocystis jirovecii remains an important cause of fatal pneumonia (Pneumocystis pneumonia or PcP) in HIV+ patients and other immunocompromised hosts. Despite many previous attempts, a clinically useful serologic test for P. jirovecii infection has never been develop...
Main Authors: | Kpandja Djawe, Laurence Huang, Kieran R Daly, Linda Levin, Judy Koch, Alexandra Schwartzman, Serena Fong, Brenna Roth, Anuradha Subramanian, Katherine Grieco, Leah Jarlsberg, Peter D Walzer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-12-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21151564/?tool=EBI |
Similar Items
-
Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time
by: Serena Fong, et al.
Published: (2013-10-01) -
Healthcare Worker Occupation and Immune Response to Pneumocystis jirovecii
by: Renuka Tipirneni, et al.
Published: (2009-10-01) -
Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia.
by: Kpandja Djawe, et al.
Published: (2013-01-01) -
Antibody Response to Pneumocystis jirovecii
by: Kieran R. Daly, et al.
Published: (2006-08-01) -
Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
by: Robert J Blount, et al.
Published: (2012-01-01)